Use cautionDrug recall · FDA · Published April 22, 2014
Recall: SigmaPharm Liothyronine Sodium 5 mcg Tablets Due to Contamination
SigmaPharm recalls specific lots of Liothyronine Sodium Tablets, USP 5 mcg due to potential cross-contamination with trace amounts of a previously manufactured product.
Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.
Take action
Contact the company
📍Recalling firmSigmaPharm Laboratories LLC3375 Progress Dr · Bensalem, PA 19020-5801
✎ GovInfoNow plain-language explainer
SigmaPharm Laboratories LLC is recalling four lots of Liothyronine Sodium Tablets, USP 5 mcg because they may contain trace amounts of a different drug due to cross-contamination. The affected products were distributed nationwide and in Puerto Rico. The record does not specify the exact nature of the contaminating product or the specific health risks involved. Read more at govinfonow.com/recall/46117-sigmapharm-laboratories-llc-recalls-liothyronine-sodium-tablets-usp-5-mcg.
“Recall: SigmaPharm Liothyronine Sodium 5 mcg Tablets Due to Contamination.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46117-sigmapharm-laboratories-llc-recalls-liothyronine-sodium-tablets-usp-5-mcg. Based on FDA recall #D-1344-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1344-2014%22&limit=1).
The FDA announced on April 22, 2014, that SigmaPharm Laboratories LLC is recalling Liothyronine Sodium Tablets, USP 5 mcg due to potential cross-contamination with trace amounts of a previously manufactured product. The agency issued recall number D-1344-2014 for the voluntary Class II action.
NDC 42794-018-06 (1000-count bottle), Lot #s: 1302202 (Exp 01/2015)
The hazard
The recall involves four lots of Liothyronine Sodium Tablets, USP 5 mcg due to the finding of a potential carryover of trace amounts of a previously manufactured product. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show SigmaPharm Laboratories LLC has three other recalls on record since April 19, 2021. Other recent recalls of similar products include Golden State Medical Supply Primidone Tablets Recall (April 27, 2026), Glenmark Bisoprolol/Hydrochlorothiazide Tablets Recall (November 21, 2025), and JB Chemicals Recalls Cetirizine Tablets Due to Cross-Contamination (June 24, 2026).
How to tell if you have this one
Check your bottle for the brand SigmaPharm Laboratories LLC and the NDC numbers 42794-018-02 (100-count) or 42794-018-06 (1000-count). Verify the lot number is one of the following: 1302201, 1305501, 1314801, or 1302202. Check the expiration date on the label.
Brand
SigmaPharm Laboratories
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check your medication
Verify if your bottle matches the SigmaPharm brand, NDC numbers, and specific lot numbers listed in the recall details.
Contact your pharmacist
If you have one of the recalled lots, speak with your pharmacist or healthcare provider immediately to determine if you should continue taking it or switch medications.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 11 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1344-2014 (April 22, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1344-2014 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.